Dr Lal Pathlabs

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE600L01024
NSEID: LALPATHLAB
BSEID: 539524
View on NSE | View on BSE

INR

1,651.70

85.05 (5.43%)

BSENSE

May 08

BSE+NSE Vol: 9.39 lacs

{
  "main_header": {
    "sid": 1000163,
    "name": "Dr Lal Pathlabs",
    "stock_name": "Dr Lal Pathlabs",
    "full_name": "Dr Lal Pathlabs Ltd",
    "name_url": "stocks-analysis/dr-lal-pathlabs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,651.70",
    "chg": 85.05,
    "chgp": "5.43%",
    "dir": 1,
    "prev_price": "1,566.65",
    "mcapval": "26,919.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539524,
    "symbol": "LALPATHLAB",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE600L01024",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "9.39 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lal-pathlabs-1000163-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Lal Pathlabs Gains 4.97%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-gains-497-6-key-factors-driving-the-weeks-momentum-3983223",
        "imagepath": "",
        "date": "2026-05-09 14:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Intraday high surge and upper circuit hit with 18.42% gain</p>\n                    <p><strong>5 May:</strong> Technical momentum shifts amid strong price rally</p>\n                    <p><strong>6 May:</strong> Mojo Score upgraded from Sell to Hold</p>\n                    <p><strong>7 May:</strong> Minor price correction amid mixed technical signals</p>\n                    <p><strong>8 May:</strong> Strong rebound closes week at Rs.1,651.70 (+5.43%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,573.45</div></div>\n                    <..."
      },
      {
        "title": "Why is Dr Lal Pathlabs Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-lal-pathlabs-ltd-fallingrising-3982548",
        "imagepath": "",
        "date": "2026-05-09 03:57:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Robust Price Momentum and Market Outperformance</strong></p>\n<p>The stock’s upward trajectory on 08-May is underscored by its impressive intraday high of ₹1,660, marking a 5.96% increase during the session. This surge notably outpaced its sector peers by 3.63%, signalling strong investor confidence in the company’s prospects. Furthermore, Dr Lal Pathlabs is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day marks, which technical analysts often interpret as a bullish indicator. This technical strength complements the fundamental factors supporting the stock’s rise.</p>\n<p><strong>Consistent Long-Term and Short-Term Returns</strong></p>\n<p>Dr Lal Pathlabs has demonstrated remarkable resilience and growth over multiple time horizons. Over the past ..."
      },
      {
        "title": "Dr Lal Pathlabs Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-upgraded-to-hold-by-marketsmojo-amid-mixed-financial-and-technical-signals-3977131",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DrLalPathlabsLt_mojoScore_3977131.png",
        "date": "2026-05-06 08:24:00",
        "description": "Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 5 May 2026. This change reflects a nuanced improvement across multiple parameters including technical indicators, valuation metrics, financial trends, and overall quality assessment. Despite some recent challenges, the company’s long-term performance and market positioning have prompted a more favourable outlook from analysts."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3976939",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DrLalPathlabsLt_technicaldot_3976939.png",
        "date": "2026-05-06 08:05:24",
        "description": "Dr Lal Pathlabs Ltd, a small-cap player in the Healthcare Services sector, has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced market sentiment as the stock navigates recent price pressures and broader sector dynamics."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Sees Technical Momentum Shift Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-sees-technical-momentum-shift-amid-strong-price-rally-3974936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DrLalPathlabsLt_technicaldot_3974936.png",
        "date": "2026-05-05 08:06:36",
        "description": "Dr Lal Pathlabs Ltd has experienced a notable shift in price momentum, reflected in a 15.01% surge in a single trading session, pushing the stock to ₹1,573.45 from the previous close of ₹1,368.10. Despite this sharp intraday rally, technical indicators present a nuanced picture, with a blend of bullish and bearish signals across weekly and monthly timeframes, prompting a reassessment of the stock’s near-term outlook."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Locks at Upper Circuit With 18.42% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-surges-to-upper-circuit-on-robust-buying-pressure-3974064",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DrLalPathlabsLt_stocks_hitting_upper_circuit_3974064.png",
        "date": "2026-05-04 12:00:08",
        "description": "At Rs 1,640.60, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Dr Lal Pathlabs Ltd locked at its upper circuit of 18.42% on 4 May 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Surges on Heavy Value Trading Amid Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-surges-on-heavy-value-trading-amid-institutional-interest-3974051",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DrLalPathlabsLt_most_active_equities_by_value_3974051.png",
        "date": "2026-05-04 12:00:07",
        "description": "Dr Lal Pathlabs Ltd witnessed a remarkable surge in trading activity on 4 May 2026, emerging as one of the most actively traded stocks by value on the bourses. The healthcare services company recorded a significant intraday rally, driven by robust institutional interest and a notable reversal in price trend after three consecutive days of decline."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Surges 10.59% to Day's High of Rs 1509.6 — Outperforms Sector by 5.22 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-hits-intraday-high-with-1059-surge-on-4-may-2026-3973682",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DrLalPathlabsLt_priceRelatedfactors_3973682.png",
        "date": "2026-05-04 10:31:06",
        "description": "The Sensex advanced 0.76% on 4 May 2026, yet Dr Lal Pathlabs Ltd outpaced the broader market with a robust 10.59% gain, reaching an intraday peak of Rs 1509.6. This 5.22 percentage-point outperformance over the Hospital & Healthcare Services sector’s 2.88% rise signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Dr Lal PathLabs Q4 FY26: Profit Surge Masks Margin Compression Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/dr-lal-pathlabs-q4-fy26-profit-surge-masks-margin-compression-concerns-3972247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DrLalPathlabs_quaterlyResult_3972247.png",
        "date": "2026-04-30 23:48:16",
        "description": "Dr Lal PathLabs Ltd., one of India's leading diagnostic service providers with a market capitalisation of ₹23,323 crores, reported a consolidated net profit of ₹131.30 crores for Q4 FY26, representing a sharp 45.08% quarter-on-quarter surge but a concerning 15.18% year-on-year decline. The stock has faced persistent selling pressure, trading at ₹1,368.10 as of April 30, 2026, down 2.10% on the day and currently 22.76% below its 52-week high of ₹1,771.30."
      }
    ],
    "total": 304,
    "sid": "1000163",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-lal-pathlabs-1000163"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "06-May-2026",
      "details": "Attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
      "datetime": "01-May-2026",
      "details": "Attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-May-2026",
      "details": "Attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has declared <strong>40%</strong> dividend, ex-date: 25 Jun 26",
          "dt": "2026-06-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 19 Dec 25",
          "dt": "2025-12-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dr Lal Pathlabs Gains 4.97%: 6 Key Factors Driving the Week’s Momentum

2026-05-09 14:00:05

Key Events This Week

4 May: Intraday high surge and upper circuit hit with 18.42% gain

5 May: Technical momentum shifts amid strong price rally

6 May: Mojo Score upgraded from Sell to Hold

7 May: Minor price correction amid mixed technical signals

8 May: Strong rebound closes week at Rs.1,651.70 (+5.43%)

Week Open

Rs.1,573.45

<...

Read full news article

Why is Dr Lal Pathlabs Ltd falling/rising?

2026-05-09 03:57:21

Robust Price Momentum and Market Outperformance

The stock’s upward trajectory on 08-May is underscored by its impressive intraday high of ₹1,660, marking a 5.96% increase during the session. This surge notably outpaced its sector peers by 3.63%, signalling strong investor confidence in the company’s prospects. Furthermore, Dr Lal Pathlabs is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day marks, which technical analysts often interpret as a bullish indicator. This technical strength complements the fundamental factors supporting the stock’s rise.

Consistent Long-Term and Short-Term Returns

Dr Lal Pathlabs has demonstrated remarkable resilience and growth over multiple time horizons. Over the past ...

Read full news article

Dr Lal Pathlabs Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals

2026-05-06 08:24:00

Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 5 May 2026. This change reflects a nuanced improvement across multiple parameters including technical indicators, valuation metrics, financial trends, and overall quality assessment. Despite some recent challenges, the company’s long-term performance and market positioning have prompted a more favourable outlook from analysts.

Read full news article

Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-06 08:05:24

Dr Lal Pathlabs Ltd, a small-cap player in the Healthcare Services sector, has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced market sentiment as the stock navigates recent price pressures and broader sector dynamics.

Read full news article

Dr Lal Pathlabs Ltd Sees Technical Momentum Shift Amid Strong Price Rally

2026-05-05 08:06:36

Dr Lal Pathlabs Ltd has experienced a notable shift in price momentum, reflected in a 15.01% surge in a single trading session, pushing the stock to ₹1,573.45 from the previous close of ₹1,368.10. Despite this sharp intraday rally, technical indicators present a nuanced picture, with a blend of bullish and bearish signals across weekly and monthly timeframes, prompting a reassessment of the stock’s near-term outlook.

Read full news article

Dr Lal Pathlabs Ltd Locks at Upper Circuit With 18.42% Gain — Buyers Queue, Sellers Absent

2026-05-04 12:00:08

At Rs 1,640.60, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Dr Lal Pathlabs Ltd locked at its upper circuit of 18.42% on 4 May 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Dr Lal Pathlabs Ltd Surges on Heavy Value Trading Amid Institutional Interest

2026-05-04 12:00:07

Dr Lal Pathlabs Ltd witnessed a remarkable surge in trading activity on 4 May 2026, emerging as one of the most actively traded stocks by value on the bourses. The healthcare services company recorded a significant intraday rally, driven by robust institutional interest and a notable reversal in price trend after three consecutive days of decline.

Read full news article

Dr Lal Pathlabs Ltd Surges 10.59% to Day's High of Rs 1509.6 — Outperforms Sector by 5.22 Percentage Points

2026-05-04 10:31:06

The Sensex advanced 0.76% on 4 May 2026, yet Dr Lal Pathlabs Ltd outpaced the broader market with a robust 10.59% gain, reaching an intraday peak of Rs 1509.6. This 5.22 percentage-point outperformance over the Hospital & Healthcare Services sector’s 2.88% rise signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Dr Lal PathLabs Q4 FY26: Profit Surge Masks Margin Compression Concerns

2026-04-30 23:48:16

Dr Lal PathLabs Ltd., one of India's leading diagnostic service providers with a market capitalisation of ₹23,323 crores, reported a consolidated net profit of ₹131.30 crores for Q4 FY26, representing a sharp 45.08% quarter-on-quarter surge but a concerning 15.18% year-on-year decline. The stock has faced persistent selling pressure, trading at ₹1,368.10 as of April 30, 2026, down 2.10% on the day and currently 22.76% below its 52-week high of ₹1,771.30.